Nichola Cooper

22PUBLICATIONS
90CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthHaematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 28, 2026
Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia.

|Jun 04, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0.

|Apr 06, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Nichola Cooper, Catherine M Broome, Yoshitaka Miyakawa

|Aug 18, 2025
Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States.

Nichola Cooper, Caroline Kruse, Sharon Deneen Morgan

|May 06, 2025
Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs.

Joana Azevedo, Jennifer DiRaimo, Cindy Neunert

|Jan 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.

Nichola Cooper, A J Gerard Jansen, Robert Bird

Pageof 4

Frequent Collaborators

5 joint publications

James Bussel

3 joint publications

A J Gerard Jansen

3 joint publications

David J Kuter

3 joint publications

Terry Gernsheimer